Report cover image

Global Gene Editing Market, 2025-2033

Publisher PreciseView Reports
Published Nov 13, 2025
Length 476 Pages
SKU # PCSR20630886

Description

Global Gene Editing Market, valued at USD 9.78 billion in 2024, is poised to advance to USD 40.59 billion by 2033, demonstrating a powerful CAGR of 17.0% across the 2025-2033 horizon. This trajectory is energized by escalating demand for precision therapeutics in rare and chronic diseases, surging adoption of CRISPR/Cas9 platforms with more than 50 active trials annually, and strides in base editing and in-vivo viral vector delivery growing at 18% CAGR for higher efficacy and reduced off-target effects. Acceleration has marked the sector since 2021, propelled by urgent COVID-19 responses, rapid scale-up of CRISPR-based clinical programs, and expanding ex-vivo editing pipelines for cell and gene therapies. Pivotal patterns spotlight CRISPR/Cas9 supremacy for simplicity and versatility, reagents & consumables commanding high-volume research spend, and drug discovery & development applications leading therapeutic innovation, with cell line and genetic engineering surging across biotech clusters. Viable gateways include North America’s robust R&D funding and clinical trial density, Europe’s academic excellence and regulatory-backed research, and Asia Pacific’s government-led initiatives and manufacturing scale in China for cost-effective platform expansion. Yet, headwinds persist with ethical and regulatory debates over germline editing constraining approvals in tightly regulated regions, high R&D and clinical scaling costs limiting accessibility in price-sensitive markets, and off-target risk scrutiny slowing diagnostics and in-vivo applications. North America grips over 40% dominion, anchored by strong biotech ecosystems and funding flows in the United States, while Asia Pacific charges ahead at 18.5% CAGR, invigorated by national genomics programs and infrastructure build-out in China and regional hubs.

Tailored breakdowns unlock targeted plays across technologies, products & services, applications, delivery modes, end-users, and terrains. Technologies crown CRISPR/Cas9 for platform versatility while base editing rises for precision; products & services lean reagents & consumables for recurring demand; applications spotlight drug discovery & development for therapeutic pipelines; delivery modes increasingly favor ex-vivo for safety and control; and end-users emphasize biotechnology & pharmaceutical companies for translational momentum, with locale-specific edges – North America for innovation and trial velocity, Asia Pacific for cost-efficient scaling, and Europe for regulatory and academic rigor.

Market Segmentation:


By Technology:

CRISPR/Cas9
TALENs
ZFNs
Base Editing
Antisense
RNAi
Others

By Product & Service:

Reagents & Consumables
Instruments
Software & Systems
Services

By Application:

Cell Line Engineering
Genetic Engineering
Drug Discovery & Development
Diagnostics
Animal Genetic Engineering
Plant Genetic Engineering
Others

By Mode of Delivery:

Ex-Vivo
In-Vivo

By End-User:

Biotechnology & Pharmaceutical Companies
Academic & Research Institutes
Contract Research Organizations (CROs)
Others

By Region:

North America (United States, Canada, Others)
Europe (United Kingdom, Germany, France, Italy, Spain, Others)
Asia Pacific (China, Japan, India, South Korea, Australia, Others)
Latin America (Brazil, Others)
Middle East & Africa (United Arab Emirates, Others)

Please note:Delivery Timeline: 2-3 Business Days

Table of Contents

476 Pages
Research Objective
MARKET SEGMENTATION
Scope of the Study
Key Questions Answered in the Report
Chapter 1 Research Methodology
1.1 Research Objective
1.2 Market Research Process
1.2.1 Data Procurement and Data Mining
1.2.2 Data Analysis and Standardization
1.2.3 Data Processing and Market Formulation
1.2.4 Data Validation
1.3 Market Research Approach
1.3.1 Residential Research
1.3.2 Commercial Research
1.3.3 Assumptions & Limitations
1.4 Year Considered for the Study
Chapter 2 Executive Summary
2.1 Global Gene Editing Market Snapshot
2.2 Global Gene Editing Market
Chapter 3 Market Variables and Scope
3.1 Introduction to Gene Editing
3.2 Classification and Scope
Chapter 4 Market Dynamics and Trends
4.1 Global Gene Editing Market Dynamics
4.2 Global Gene Editing Market Dynamics, Impact Analysis
4.3 Market Drivers
4.3.1 Driver 1
4.3.2 Driver 2
4.4 Market Restraints
4.4.1 Restraint 1
4.4.2 Restraint 2
4.5 Market Opportunity
4.5.1 Opportunity 1
4.5.2 Opportunity 2
Chapter 5 Premium Insights
5.1 Porter’s Five Forces Analysis
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of Substitute Types
5.1.4 Rivalry among Existing Firms
5.1.5 Threat of New Entrants
5.2 Supply Chain Analysis
5.3 Market Share Analysis of Key Players, 2024
5.4 Market Entry Strategy Assessment
5.5 Strategic Recommendation for Stakeholders
Chapter 6 Global Gene Editing Market, By Technology
6.1 Global Gene Editing Market, By Technology, 2025 - 2033
6.2 CRISPR/Cas9
6.3 TALENs
6.4 ZFNs
6.5 Base Editing
6.6 Antisense
6.7 RNAi
6.8 Others
Chapter 7 Global Gene Editing Market, By Product & Service
7.1 Global Gene Editing Market, By Product & Service, 2025 - 2033
7.2 Reagents & Consumables
7.3 Instruments
7.4 Software & Systems
7.5 Services
Chapter 8 Global Gene Editing Market, By Application
8.1 Global Gene Editing Market, By Application, 2025 - 2033
8.2 Cell Line Engineering
8.3 Genetic Engineering
8.4 Drug Discovery & Development
8.5 Diagnostics
8.6 Animal Genetic Engineering
8.7 Plant Genetic Engineering
8.8 Others
Chapter 9 Global Gene Editing Market, By Mode of Delivery
9.1 Global Gene Editing Market, By Mode of Delivery, 2025 - 2033
9.2 Ex-Vivo
9.3 In-Vivo
Chapter 10 Global Gene Editing Market, By End-User
10.1 Global Gene Editing Market, By End-User, 2025 - 2033
10.2 Biotechnology & Pharmaceutical Companies
10.3 Academic & Research Institutes
10.4 Contract Research Organizations (CROs)
10.5 Others
Chapter 11 Global Gene Editing Market, By Region
11.1 Overview
11.2 North America
11.2.1 North America Gene Editing Market, By Country
11.2.2 North America Gene Editing Market, By Technology
11.2.3 North America Gene Editing Market, By Product & Service
11.2.4 North America Gene Editing Market, By Application
11.2.5 North America Gene Editing Market, By Mode of Delivery
11.2.6 North America Gene Editing Market, By End-User
11.2.7 United States
11.2.7.1 United States Gene Editing Market, By Technology
11.2.7.2 United States Gene Editing Market, By Product & Service
11.2.7.3 United States Gene Editing Market, By Application
11.2.7.4 United States Gene Editing Market, By Mode of Delivery
11.2.7.5 United States Gene Editing Market, By End-User
11.2.8 Canada
11.2.8.1 Canada Gene Editing Market, By Technology
11.2.8.2 Canada Gene Editing Market, By Product & Service
11.2.8.3 Canada Gene Editing Market, By Application
11.2.8.4 Canada Gene Editing Market, By Mode of Delivery
11.2.8.5 Canada Gene Editing Market, By End-User
11.2.9 Others
11.2.9.1 Others Gene Editing Market, By Technology
11.2.9.2 Others Gene Editing Market, By Product & Service
11.2.9.3 Others Gene Editing Market, By Application
11.2.9.4 Others Gene Editing Market, By Mode of Delivery
11.2.9.5 Others Gene Editing Market, By End-User
11.3 Europe
11.3.1 Europe Gene Editing Market, By Country
11.3.2 Europe Gene Editing Market, By Technology
11.3.3 Europe Gene Editing Market, By Product & Service
11.3.4 Europe Gene Editing Market, By Application
11.3.5 Europe Gene Editing Market, By Mode of Delivery
11.3.6 Europe Gene Editing Market, By End-User
11.3.7 United Kingdom
11.3.7.1 United Kingdom Gene Editing Market, By Technology
11.3.7.2 United Kingdom Gene Editing Market, By Product & Service
11.3.7.3 United Kingdom Gene Editing Market, By Application
11.3.7.4 United Kingdom Gene Editing Market, By Mode of Delivery
11.3.7.5 United Kingdom Gene Editing Market, By End-User
11.3.8 Germany
11.3.8.1 Germany Gene Editing Market, By Technology
11.3.8.2 Germany Gene Editing Market, By Product & Service
11.3.8.3 Germany Gene Editing Market, By Application
11.3.8.4 Germany Gene Editing Market, By Mode of Delivery
11.3.8.5 Germany Gene Editing Market, By End-User
11.3.9 France
11.3.9.1 France Gene Editing Market, By Technology
11.3.9.2 France Gene Editing Market, By Product & Service
11.3.9.3 France Gene Editing Market, By Application
11.3.9.4 France Gene Editing Market, By Mode of Delivery
11.3.9.5 France Gene Editing Market, By End-User
11.3.10 Italy
11.3.10.1 Italy Gene Editing Market, By Technology
11.3.10.2 Italy Gene Editing Market, By Product & Service
11.3.10.3 Italy Gene Editing Market, By Application
11.3.10.4 Italy Gene Editing Market, By Mode of Delivery
11.3.10.5 Italy Gene Editing Market, By End-User
11.3.11 Spain
11.3.11.1 Spain Gene Editing Market, By Technology
11.3.11.2 Spain Gene Editing Market, By Product & Service
11.3.11.3 Spain Gene Editing Market, By Application
11.3.11.4 Spain Gene Editing Market, By Mode of Delivery
11.3.11.5 Spain Gene Editing Market, By End-User
11.3.12 Others
11.3.12.1 Others Gene Editing Market, By Technology
11.3.12.2 Others Gene Editing Market, By Product & Service
11.3.12.3 Others Gene Editing Market, By Application
11.3.12.4 Others Gene Editing Market, By Mode of Delivery
11.3.12.5 Others Gene Editing Market, By End-User
11.4 Asia Pacific
11.4.1 Asia Pacific Gene Editing Market, By Country
11.4.2 Asia Pacific Gene Editing Market, By Technology
11.4.3 Asia Pacific Gene Editing Market, By Product & Service
11.4.4 Asia Pacific Gene Editing Market, By Application
11.4.5 Asia Pacific Gene Editing Market, By Mode of Delivery
11.4.6 Asia Pacific Gene Editing Market, By End-User
11.4.7 China
11.4.7.1 China Gene Editing Market, By Technology
11.4.7.2 China Gene Editing Market, By Product & Service
11.4.7.3 China Gene Editing Market, By Application
11.4.7.4 China Gene Editing Market, By Mode of Delivery
11.4.7.5 China Gene Editing Market, By End-User
11.4.8 Japan
11.4.8.1 Japan Gene Editing Market, By Technology
11.4.8.2 Japan Gene Editing Market, By Product & Service
11.4.8.3 Japan Gene Editing Market, By Application
11.4.8.4 Japan Gene Editing Market, By Mode of Delivery
11.4.8.5 Japan Gene Editing Market, By End-User
11.4.9 India
11.4.9.1 India Gene Editing Market, By Technology
11.4.9.2 India Gene Editing Market, By Product & Service
11.4.9.3 India Gene Editing Market, By Application
11.4.9.4 India Gene Editing Market, By Mode of Delivery
11.4.9.5 India Gene Editing Market, By End-User
11.4.10 South Korea
11.4.10.1 South Korea Gene Editing Market, By Technology
11.4.10.2 South Korea Gene Editing Market, By Product & Service
11.4.10.3 South Korea Gene Editing Market, By Application
11.4.10.4 South Korea Gene Editing Market, By Mode of Delivery
11.4.10.5 South Korea Gene Editing Market, By End-User
11.4.11 Australia
11.4.11.1 Australia Gene Editing Market, By Technology
11.4.11.2 Australia Gene Editing Market, By Product & Service
11.4.11.3 Australia Gene Editing Market, By Application
11.4.11.4 Australia Gene Editing Market, By Mode of Delivery
11.4.11.5 Australia Gene Editing Market, By End-User
11.4.12 Others
11.4.12.1 Others Gene Editing Market, By Technology
11.4.12.2 Others Gene Editing Market, By Product & Service
11.4.12.3 Others Gene Editing Market, By Application
11.4.12.4 Others Gene Editing Market, By Mode of Delivery
11.4.12.5 Others Gene Editing Market, By End-User
11.5 Latin America
11.5.1 Latin America Gene Editing Market, By Country
11.5.2 Latin America Gene Editing Market, By Technology
11.5.3 Latin America Gene Editing Market, By Product & Service
11.5.4 Latin America Gene Editing Market, By Application
11.5.5 Latin America Gene Editing Market, By Mode of Delivery
11.5.6 Latin America Gene Editing Market, By End-User
11.5.7 Brazil
11.5.7.1 Brazil Gene Editing Market, By Technology
11.5.7.2 Brazil Gene Editing Market, By Product & Service
11.5.7.3 Brazil Gene Editing Market, By Application
11.5.7.4 Brazil Gene Editing Market, By Mode of Delivery
11.5.7.5 Brazil Gene Editing Market, By End-User
11.5.8 Others
11.5.8.1 Others Gene Editing Market, By Technology
11.5.8.2 Others Gene Editing Market, By Product & Service
11.5.8.3 Others Gene Editing Market, By Application
11.5.8.4 Others Gene Editing Market, By Mode of Delivery
11.5.8.5 Others Gene Editing Market, By End-User
11.6 Middle East and Africa (MEA)
11.6.1 Middle East and Africa (MEA) Gene Editing Market, By Country
11.6.2 Middle East and Africa (MEA) Gene Editing Market, By Technology
11.6.3 Middle East and Africa (MEA) Gene Editing Market, By Product & Service
11.6.4 Middle East and Africa (MEA) Gene Editing Market, By Application
11.6.5 Middle East and Africa (MEA) Gene Editing Market, By Mode of Delivery
11.6.6 Middle East and Africa (MEA) Gene Editing Market, By End-User
11.6.7 United Arab Emirates
11.6.7.1 United Arab Emirates Gene Editing Market, By Technology
11.6.7.2 United Arab Emirates Gene Editing Market, By Product & Service
11.6.7.3 United Arab Emirates Gene Editing Market, By Application
11.6.7.4 United Arab Emirates Gene Editing Market, By Mode of Delivery
11.6.7.5 United Arab Emirates Gene Editing Market, By End-User
11.6.8 Others
11.6.8.1 Others Gene Editing Market, By Technology
11.6.8.2 Others Gene Editing Market, By Product & Service
11.6.8.3 Others Gene Editing Market, By Application
11.6.8.4 Others Gene Editing Market, By Mode of Delivery
11.6.8.5 Others Gene Editing Market, By End-User
Chapter 12 Competitive Landscape
12.1 Strategic Move Analysis
12.1.1 Top Player Positioning/Market Share Analysis
12.1.2 Top Winning Strategies, By Year, 2021-2024
12.1.3 Competitive Analysis by Revenue, 2022-2024
12.2 Recent Developments by the Market Participants (2024-25)
Chapter 13 Company Profiles
13.1 CRISPR Therapeutics AG
13.1.1 Company Snapshot
13.1.2 Company Overview
13.1.3 Financial Performance
13.1.4 Product Portfolio
13.1.5 Strategic Growth
13.2 Editas Medicine Inc.
13.2.1 Company Snapshot
13.2.2 Company Overview
13.2.3 Financial Performance
13.2.4 Product Portfolio
13.2.5 Strategic Growth
13.3 Intellia Therapeutics Inc.
13.3.1 Company Snapshot
13.3.2 Company Overview
13.3.3 Financial Performance
13.3.4 Product Portfolio
13.3.5 Strategic Growth
13.4 Caribou Biosciences Inc.
13.4.1 Company Snapshot
13.4.2 Company Overview
13.4.3 Financial Performance
13.4.4 Product Portfolio
13.4.5 Strategic Growth
13.5 Beam Therapeutics Inc.
13.5.1 Company Snapshot
13.5.2 Company Overview
13.5.3 Financial Performance
13.5.4 Product Portfolio
13.5.5 Strategic Growth
13.6 Sangamo Therapeutics Inc.
13.6.1 Company Snapshot
13.6.2 Company Overview
13.6.3 Financial Performance
13.6.4 Product Portfolio
13.6.5 Strategic Growth
13.7 Precision BioSciences Inc.
13.7.1 Company Snapshot
13.7.2 Company Overview
13.7.3 Financial Performance
13.7.4 Product Portfolio
13.7.5 Strategic Growth
13.8 Cellectis S.A.
13.8.1 Company Snapshot
13.8.2 Company Overview
13.8.3 Financial Performance
13.8.4 Product Portfolio
13.8.5 Strategic Growth
13.9 bluebird bio Inc.
13.9.1 Company Snapshot
13.9.2 Company Overview
13.9.3 Financial Performance
13.9.4 Product Portfolio
13.9.5 Strategic Growth
13.10 Verve Therapeutics Inc.
13.10.1 Company Snapshot
13.10.2 Company Overview
13.10.3 Financial Performance
13.10.4 Product Portfolio
13.10.5 Strategic Growth
13.11 Allogene Therapeutics Inc.
13.11.1 Company Snapshot
13.11.2 Company Overview
13.11.3 Financial Performance
13.11.4 Product Portfolio
13.11.5 Strategic Growth
13.12 Fate Therapeutics Inc.
13.12.1 Company Snapshot
13.12.2 Company Overview
13.12.3 Financial Performance
13.12.4 Product Portfolio
13.12.5 Strategic Growth
13.13 Poseida Therapeutics Inc.
13.13.1 Company Snapshot
13.13.2 Company Overview
13.13.3 Financial Performance
13.13.4 Product Portfolio
13.13.5 Strategic Growth
13.14 CRISPR Biotechnologies
13.14.1 Company Snapshot
13.14.2 Company Overview
13.14.3 Financial Performance
13.14.4 Product Portfolio
13.14.5 Strategic Growth
13.15 eTree Diagnostics
13.15.1 Company Snapshot
13.15.2 Company Overview
13.15.3 Financial Performance
13.15.4 Product Portfolio
13.15.5 Strategic Growth

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us